Trademark: 87522915
Word
PUMAPATIENTLYNX
Status Date
Monday, March 11, 2019
Filing Date
Tuesday, July 11, 2017
Published for Opposition
Tuesday, December 12, 2017
Abandoned Date
Monday, March 11, 2019
5 pharmaceutical products for the prevention and treatment of cancer
The color(s) gray, blue, and gold is/are claimed as a feature of the mark.
The mark consists of "PUMA" in gray, "PATIENT" in blue, and "LYNX" in gold with a blue dot below the "X".
Mar 11, 2019
Abandonment Notice E-Mailed - No Use Statement Filed
Mar 11, 2019
Abandonment - No Use Statement Filed
Jun 15, 2018
Notice Of Approval Of Extension Request E-Mailed
Jun 13, 2018
Extension 1 Granted
Jun 13, 2018
Extension 1 Filed
Jun 13, 2018
Teas Extension Received
Feb 6, 2018
Noa E-Mailed - Sou Required From Applicant
Dec 12, 2017
Official Gazette Publication Confirmation E-Mailed
Dec 12, 2017
Published For Opposition
Nov 22, 2017
Notification Of Notice Of Publication E-Mailed
Nov 3, 2017
Assigned To Lie
Oct 22, 2017
Approved For Pub - Principal Register
Oct 18, 2017
Teas/Email Correspondence Entered
Oct 18, 2017
Correspondence Received In Law Office
Oct 18, 2017
Teas Response To Office Action Received
Oct 12, 2017
Notification Of Priority Action E-Mailed
Oct 12, 2017
Priority Action E-Mailed
Oct 12, 2017
Priority Action Written
Oct 9, 2017
Assigned To Examiner
Jul 18, 2017
Notice Of Design Search Code E-Mailed
Jul 17, 2017
New Application Office Supplied Data Entered In Tram
Jul 14, 2017
New Application Entered In Tram
Trademark Alertz updated from USPTO on 2030-01-24